Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN2A | Q99250 | 9/20 | 0.53 |
| ▸ | SCN5A | Q14524 | 8/20 | 0.53 |
| ▸ | POLB | P06746 | 2/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | CCR6 | P51684 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 3/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.49 |
| ▸ | MAPT | P10636 | 2/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | NPC1 | O15118 | 3/20 | 0.49 |
| ▸ | RAB9A | P51151 | 3/20 | 0.49 |
| ▸ | CES2 | O00748 | 1/20 | 0.45 |
| ▸ | CES1 | P23141 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5836703 | 1.00 | SCN2A (0.53) | SCN2ASCN5APOLBLMNACCR6 | |
| Hydrochloric Acid SCHEMBL5700459 | 0.97 | SCN2A (0.51) | SCN2ASCN5APOLBLMNACCR6 | |
| SCHEMBL5836768 | 0.95 | SCN2A (0.49) | SCN2ASCN5APOLBLMNACCR6 | |
| SCHEMBL6463624 | 0.78 | LMNA (0.69) | SCN2APOLBLMNACCR6MEN1 | |
| SCHEMBL5700582 | 0.77 | SMN1; SMN2 (0.42) | SCN2ASCN5APOLBLMNAMEN1 | |
| SCHEMBL5700585 | 0.77 | SMN1; SMN2 (0.42) | SCN2ASCN5APOLBLMNAMEN1 | |
| Hydrochloric Acid SCHEMBL5700596 | 0.74 | SMN1; SMN2 (0.40) | SCN2ASCN5APOLBLMNAMEN1 | |
| SCHEMBL5700600 | 0.72 | SMN1; SMN2 (0.39) | SCN2ASCN5APOLBLMNAMEN1 | |
| SCHEMBL5166735 | 0.70 | ALDH1A1 (0.83) | POLBLMNACCR6MEN1KMT2A | |
| SCHEMBL28463608 | 0.70 | CCR6 (0.59) | SCN2APOLBLMNACCR6MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7141687-B2 | N'-substituted N-acylamidine metal transition complexes and their use as catalysts | BASF AKTIENGESELLSCHAFT (DE) | 2006-11-28 | — | — | US | disclosed |
| EP-1569947-B1 | N'-SUBSTITUTED N-ACYLAMIDINE METAL TRANSITION COMPLEXES AND THEIR USE AS CATALYSTS | BASF AG (DE) | 2006-08-30 | — | — | EP | disclosed |
| US-20060069275-A1 | N'-substituded n-acylamidine metal transition complexes and their use as catalysts | BASF AKTIENGESELLSCHAFT (DE) | 2006-03-30 | — | — | US | disclosed |
| EP-1569947-A1 | N'-SUBSTITUTED N-ACYLAMIDINE METAL TRANSITION COMPLEXES AND THEIR USE AS CATALYSTS | BASF AKTIENGESELLSCHAFT (DE) | 2005-09-07 | — | — | EP | disclosed |
| WO-2004050670-A1 | N'-SUBSTITUTED N-ACYLAMIDINE METAL TRANSITION COMPLEXES AND THEIR USE AS CATALYSTS | BASF AKTIENGESELLSCHAFT (DE) | 2004-06-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060069275-A1 | N'-substituded n-acylamidine metal transition complexes and their use as catalysts | NR1I3, NR0B1, NR4A1 | SCN2A 761/4885SCN5A 1024/4885POLB 3023/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.